NTRR — Neutra Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Neutra, fiscal year end - January 31st, USD millions except per share, conversion factor applied.

	2020 January 31st	2021 January 31st	2022 January 31st	2023 January 31st	2024 January 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	U USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.006	0.01	0.092	0.068	0.04
Cost of Revenue
Gross Profit	—	-0.033	0.031	0.035	0.014
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	0.361	0.427	0.664	0.564	0.269
Operating Profit	-0.355	-0.417	-0.572	-0.496	-0.229
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.696	-0.539	-0.633	-0.558	-0.233
Provision for Income Taxes
Net Income After Taxes	-0.696	-0.539	-0.633	-0.561	-0.233
Net Income Before Extraordinary Items
Net Income	-0.696	-0.539	-0.633	-0.561	-0.233
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.696	-0.581	-0.742	-0.577	-0.233
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.003	-0.001	-0	-0	-0